Manuel Graiwer insider trades: Duska Therapeutics (DSKA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Manuel reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2008 | DSKA | ↑ Buy | 14,749 | $0.55 | $8K | Direct | Mar 17, 2008 (13d) |
| Apr 10, 2007 | DSKA | ↑ Buy | 57,217 | $0.30 | $17K | Direct | Feb 20, 2008 (316d) |
| Mar 9, 2007 | DSKT | ↑ Buy | 5,416,921 | $0.02 | $108K | Direct | Mar 9, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Manuel Graiwer's insider trades
Manuel Graiwer is a director at Duska Therapeutics (DSKA). Since Mar 9, 2007, Manuel has reported 3 open-market purchases worth $134K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DSKA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.